Skip to main content
Erschienen in: Acta Neurochirurgica 3/2017

21.11.2016 | Case Report - Brain Tumors

Spontaneous regression of a parafalcine meningioma in a multiple sclerosis patient being treated with interferon beta-1a

Erschienen in: Acta Neurochirurgica | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Regression of meningioma after haemorrhage and the cessation of hormone treatment is well reported. However, spontaneous regression is very rarely observed. Here, we report the spontaneous regression of a parafalcine meningioma in a 56-year-old woman with multiple sclerosis, who was referred to our department after an incidental finding on magnetic resonance imaging. She was being treated with interferon beta-1a to manage the symptoms. To our knowledge, this is the first report of spontaneous regression of meningioma in a patient receiving interferon beta-1a therapy and just the second report of spontaneous regression in general.
Literatur
1.
Zurück zum Zitat Batay F, Al-Merfy O (2002) Growth dynamics of meningiomas in patients with multiple sclerosis treated with interferon: report in two cases. Acta Neurochir (Wein) 144:365–368CrossRef Batay F, Al-Merfy O (2002) Growth dynamics of meningiomas in patients with multiple sclerosis treated with interferon: report in two cases. Acta Neurochir (Wein) 144:365–368CrossRef
2.
Zurück zum Zitat Cea-Soriano L, Wallander M, García RL (2012) Epidemiology of Meningioma in the United Kingdom. Neuroepidemiology 39(1):27–34CrossRefPubMed Cea-Soriano L, Wallander M, García RL (2012) Epidemiology of Meningioma in the United Kingdom. Neuroepidemiology 39(1):27–34CrossRefPubMed
3.
Zurück zum Zitat Ricci SB, Cerchiari U (2010) Spontaneous regression of malignant tumors: importance of the immune system and other factors (Review). Oncol Lett 1(6)941-945 Ricci SB, Cerchiari U (2010) Spontaneous regression of malignant tumors: importance of the immune system and other factors (Review). Oncol Lett 1(6)941-945
4.
Zurück zum Zitat de Almeida J, Petteys R, Sciubba D, Gallia G, Brem H (2009) Regression of intracranial meningioma following intratumoral haemorrhage. J Clin Neurosci 16(9):1246–1249CrossRefPubMed de Almeida J, Petteys R, Sciubba D, Gallia G, Brem H (2009) Regression of intracranial meningioma following intratumoral haemorrhage. J Clin Neurosci 16(9):1246–1249CrossRefPubMed
5.
Zurück zum Zitat Dekkers OM, Pereira AM, Romijn JA (2008) Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab 93:3717–26CrossRefPubMed Dekkers OM, Pereira AM, Romijn JA (2008) Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab 93:3717–26CrossRefPubMed
6.
Zurück zum Zitat Drevelegas A, Xinou E, Karacostas D, Parissis D, Karlavelas G, Milonas I (2005) Meningioma growth and interferon beta-1B treated multiple sclerosis: coincidence or relationship? Neuroradiology 47(7):516–519CrossRefPubMed Drevelegas A, Xinou E, Karacostas D, Parissis D, Karlavelas G, Milonas I (2005) Meningioma growth and interferon beta-1B treated multiple sclerosis: coincidence or relationship? Neuroradiology 47(7):516–519CrossRefPubMed
7.
Zurück zum Zitat Gama H, Rocha A, Silva C, Mendes M, Veiga J, Lancellotti C, Andrade V, Tilbery C (2008) Meningioma growth during interferon beta-1A treatment for multiple sclerosis. Arq Neuro-Psiquiatr 66(2):402–404CrossRef Gama H, Rocha A, Silva C, Mendes M, Veiga J, Lancellotti C, Andrade V, Tilbery C (2008) Meningioma growth during interferon beta-1A treatment for multiple sclerosis. Arq Neuro-Psiquiatr 66(2):402–404CrossRef
8.
Zurück zum Zitat Goncalves A, Page P, Domigo V, Meder J, Oppenheim C (2010) Abrupt regression of a meningioma after discontinuation of cyproterone treatment. AJNR Am J Neuroradiol 31(8):1504–1505CrossRefPubMed Goncalves A, Page P, Domigo V, Meder J, Oppenheim C (2010) Abrupt regression of a meningioma after discontinuation of cyproterone treatment. AJNR Am J Neuroradiol 31(8):1504–1505CrossRefPubMed
9.
Zurück zum Zitat Hashiba T, Hashimoto N, Izumoto S, Suzuki T, Kagawa N, Maruno M, Kato A, Yoshimine T (2009) Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. J Neurosurg 110(4):675–684CrossRefPubMed Hashiba T, Hashimoto N, Izumoto S, Suzuki T, Kagawa N, Maruno M, Kato A, Yoshimine T (2009) Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. J Neurosurg 110(4):675–684CrossRefPubMed
10.
Zurück zum Zitat Huang X, Caye-Thomasen P, Stangerup S (2013) Spontaneous tumour shrinkage in 1261 observed patients with sporadic vestibular schwannoma. J Laryngol Otol 127:739–743CrossRefPubMed Huang X, Caye-Thomasen P, Stangerup S (2013) Spontaneous tumour shrinkage in 1261 observed patients with sporadic vestibular schwannoma. J Laryngol Otol 127:739–743CrossRefPubMed
11.
Zurück zum Zitat Janiszewska A, Poletajew S, Wasiutyński A (2013) Reviews Spontaneous regression of renal cell carcinoma. Contemp Oncol 2:123–127 Janiszewska A, Poletajew S, Wasiutyński A (2013) Reviews Spontaneous regression of renal cell carcinoma. Contemp Oncol 2:123–127
12.
Zurück zum Zitat Kaba S, De Monte F, Bruner J, Kyritsis A, Jaekle K, Levin V, Yung A (1997) The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2b. Neurosurgery 40(2):271–275CrossRefPubMed Kaba S, De Monte F, Bruner J, Kyritsis A, Jaekle K, Levin V, Yung A (1997) The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2b. Neurosurgery 40(2):271–275CrossRefPubMed
13.
Zurück zum Zitat Kasuya H, Akagawa H, Fujita T, Hirota K, Onda H (2014) Spontaneous regression together with increased calcification of incidental meningioma. Surg Neurol Int 5(1):73CrossRefPubMedPubMedCentral Kasuya H, Akagawa H, Fujita T, Hirota K, Onda H (2014) Spontaneous regression together with increased calcification of incidental meningioma. Surg Neurol Int 5(1):73CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Liu A, Wang J, Li G, Sun Y, Sun S, Luo B, Wang M (2014) Clinical and pathological analysis of benign brain tumors resected after gamma knife surgery. J Neurosurg 121:179–187PubMed Liu A, Wang J, Li G, Sun Y, Sun S, Luo B, Wang M (2014) Clinical and pathological analysis of benign brain tumors resected after gamma knife surgery. J Neurosurg 121:179–187PubMed
15.
Zurück zum Zitat Moller H, Kneller R, Boice J, Olsen J (1991) Cancer incidence following hospitalization for multiple sclerosis in Denmark. Acta Neurol Scand 84:214–220CrossRefPubMed Moller H, Kneller R, Boice J, Olsen J (1991) Cancer incidence following hospitalization for multiple sclerosis in Denmark. Acta Neurol Scand 84:214–220CrossRefPubMed
16.
Zurück zum Zitat Stewart F (1952) Experiences in spontaneous regression of neoplastic disease in man. Texas Rep Biol Med 10:239–253 Stewart F (1952) Experiences in spontaneous regression of neoplastic disease in man. Texas Rep Biol Med 10:239–253
17.
Zurück zum Zitat Vieira R, Vale T, Rocha C, Araújo C, Lana-Peixoto M (2012) Meningioma after immunomodulation for multiple sclerosis. Arq Neuro-Psiquiatr 70(1):75–76CrossRef Vieira R, Vale T, Rocha C, Araújo C, Lana-Peixoto M (2012) Meningioma after immunomodulation for multiple sclerosis. Arq Neuro-Psiquiatr 70(1):75–76CrossRef
18.
Zurück zum Zitat Weinstock B, Ramanathan M, Zivadinov R (2008) Interferon-beta treatment for relapsing multiple sclerosis. Expert Opin Biol Ther 8(9):1435–1447CrossRef Weinstock B, Ramanathan M, Zivadinov R (2008) Interferon-beta treatment for relapsing multiple sclerosis. Expert Opin Biol Ther 8(9):1435–1447CrossRef
Metadaten
Titel
Spontaneous regression of a parafalcine meningioma in a multiple sclerosis patient being treated with interferon beta-1a
Publikationsdatum
21.11.2016
Erschienen in
Acta Neurochirurgica / Ausgabe 3/2017
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-016-3019-6

Weitere Artikel der Ausgabe 3/2017

Acta Neurochirurgica 3/2017 Zur Ausgabe

Letter to the editor - Obituary

João Lobo Antunes, 1944–2016

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.